KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Equity Ratio: 2009-2025

Historic Equity Ratio for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to 0.50.

  • Thermo Fisher Scientific's Equity Ratio rose 1.50% to 0.50 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.50, marking a year-over-year increase of 1.50%. This contributed to the annual value of 0.51 for FY2024, which is 7.63% up from last year.
  • Thermo Fisher Scientific's Equity Ratio amounted to 0.50 in Q3 2025, which was down 0.74% from 0.50 recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Equity Ratio registered a high of 0.54 during Q3 2021, and its lowest value of 0.43 during Q4 2021.
  • Its 3-year average for Equity Ratio is 0.48, with a median of 0.48 in 2024.
  • In the last 5 years, Thermo Fisher Scientific's Equity Ratio rose by 12.24% in 2021 and then declined by 16.83% in 2022.
  • Over the past 5 years, Thermo Fisher Scientific's Equity Ratio (Quarterly) stood at 0.43 in 2021, then rose by 5.52% to 0.45 in 2022, then grew by 4.45% to 0.47 in 2023, then grew by 7.63% to 0.51 in 2024, then increased by 1.50% to 0.50 in 2025.
  • Its Equity Ratio was 0.50 in Q3 2025, compared to 0.50 in Q2 2025 and 0.50 in Q1 2025.